x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharma and BioTech Daily

Pharma and BioTech News

Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai

news tech news

All Episodes

13:14

Breakthroughs and Strategic Shifts in Pharma & Biotech

Pharma and BioTech Daily ·

2025/11/20

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the intricate tapestry of scientific advancements, regulatory decisions, and strategic maneuvers shaping our industry.One of the notable stories involves Agios Pharmaceuticals, which is pushing forward with its sickle cell disease treatment, Pyrukynd, for FDA approval. This comes despite mixed results from their Phase 3 clinic...

en-us

7:00

Pharma Breakthroughs: Regeneron, CSL, and Merck Lead

Pharma and BioTech Daily ·

2025/11/19

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of the industry, exploring significant scientific advancements, regulatory changes, clinical trial outcomes, and strategic investments that are shaping the future of healthcare.Starting with strategic investments, Regeneron is making a bold move with a $2 billion investment to transform a former magazine ...

en-us

6:12

Oncology Breakthroughs and Strategic Acquisitions...

Pharma and BioTech Daily ·

2025/11/18

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a host of transformative events reshaping the landscape, from strategic acquisitions and funding infusions to regulatory maneuvers and scientific breakthroughs.Johnson & Johnson has taken a decisive step in its oncology strategy with the $3 billion acquisition of Halda's cell death technology. This acquisition, focusing on...

en-us

4:55

Strategic Shifts and Breakthroughs in Pharma Innovation

Pharma and BioTech Daily ·

2025/11/17

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a myriad of pivotal changes and advancements that have been shaping our industry.The competitive nature of acquisitions within the biopharma sector has been exemplified by recent strategic buyouts. Lundbeck's decision to outbid Alkermes for Avadel Pharmaceuticals highlights how companies are leveraging acquisitions to expa...

en-us

6:27

Revolutionizing Personalized Medicine: FDA's New Pathway

Pharma and BioTech Daily ·

2025/11/14

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into several groundbreaking advancements and strategic shifts in the industry that promise to reshape the landscape of patient care and therapeutic innovations.The U.S. Food and Drug Administration has introduced a novel regulatory pathway aimed at expediting the approval process for custom gene-editing therapies. Articulated b...

en-us

6:46

Revolutionizing Oncology: Pfizer's PD-1xVEGF...

Pharma and BioTech Daily ·

2025/11/13

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling updates that underscore the dynamic nature of our industry, marked by scientific breakthroughs, strategic shifts, regulatory advancements, and more.Starting with Pfizer's ambitious endeavors in oncology, the company has initiated Phase 3 trials for its bispecific antibody PF-08634404, targeting non-small...

en-us

5:59

Strategic Acquisitions and Breakthrough Partnerships...

Pharma and BioTech Daily ·

2025/11/12

Send us a text Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking changes and innovations reshaping the landscape of drug development, clinical trials, and regulatory affairs.In a major move, Pfizer has successfully outbid Novo Nordisk to acquire Metsera for $10 billion. This strategic acquisition aims to bolster Pfizer's presence in the obesity treatment market by...

en-us

6:26

Revolutionizing Drug Development: Key Breakthroughs...

Pharma and BioTech Daily ·

2025/11/11

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In today's rapidly evolving landscape, we witness significant strides shaping the future of drug development, patient care, and global market dynamics.Merck & Co. has made a notable advancement in cholesterol management with a PCSK9-targeted pill. This pill has achieved reductions in low-density lipoprotein cholesterol (LDL-C) comparable to ex...

en-us

7:23

FDA Milestones and Oncology Innovations: Key Industry...

Pharma and BioTech Daily ·

2025/11/10

Send us a text Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking developments that are reshaping the landscape of drug development and patient care. These stories highlight the dynamic nature of the pharmaceutical and biotechnology industries, where scientific advancements and regulatory changes are driving significant shifts.We begin with a crucial milestone ...

en-us

8:29

Transformative Therapies: Innovations and Regulatory...

Pharma and BioTech Daily ·

2025/11/05

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore a series of groundbreaking advancements and strategic collaborations that promise to transform drug development and patient care.In the autoimmune space, Boehringer Ingelheim has made a significant move by securing a $570 million agreement with CDR-Life. This deal centers on a trispecific antibody, a novel therapeutic approach that targets mult...

en-us

8:20

**Industry Shifts: Mergers, Regulations, and Biotech...

Pharma and BioTech Daily ·

2025/11/04

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events reshaping the landscape of healthcare, from strategic mergers and regulatory shifts to groundbreaking advancements in drug development.Let's begin with a monumental merger that signals a shift towards more integrated healthcare solutions. The $48.7 billion acquisition of Kenvue, a consumer health spinout...

en-us

7:18

Precision Oncology and HIV Prevention Breakthroughs

Pharma and BioTech Daily ·

2025/11/03

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating advancements and strategic movements that are shaping the landscape of drug development and patient care.Starting with a significant milestone in precision oncology, China has approved its first EGFR-targeted antibody-drug conjugate. This approval marks a pivotal moment in the industry’s shift towards targeted the...

en-us

33:50

Week in Review November 1st

Pharma and BioTech Daily ·

2025/11/01

This Week in Review covers 5 episodes from October 27 to October 31, featuring major developments in the pharmaceutical and biotech industries. Episodes included: 1. Pharma Shifts: Dual-Action Obesity Drugs & Regulatory Waves 2. Navigating Pharma's New Frontiers: Breakthroughs and Challenges 3. Gene Therapy Challenges and Regulatory Shifts: Industry Innovations 4. Biotech Breakthroughs: Transformative Acquisitions and FDA Milestones 5. Novartis' $12B RNA Therapeutics Breakthrough Key topi...

en-us

7:12

Pharma Shifts: Dual-Action Obesity Drugs & Regulatory...

Pharma and BioTech Daily ·

2025/10/31

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's focus is on a series of significant advancements that are poised to reshape the landscape of drug development, regulatory standards, and patient care.Eli Lilly has made remarkable strides with its dual-action obesity medications, Zepbound and Mounjaro. Despite being removed from the CVS formulary, these drugs have achieved exceptional sales figures, reac...

en-us

6:20

Navigating Pharma's New Frontiers: Breakthroughs and...

Pharma and BioTech Daily ·

2025/10/30

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're exploring a series of significant developments that underscore the rapid evolution within these industries.Starting with one of the major players, Merck, which has been strategically adjusting its focus in light of Keytruda's looming loss of exclusivity. The company has demonstrated remarkable progress with Welireg in kidney cancer trials, successfu...

en-us

8:09

Gene Therapy Challenges and Regulatory Shifts:...

Pharma and BioTech Daily ·

2025/10/29

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a dynamic landscape of scientific breakthroughs, regulatory shifts, and strategic maneuvers reshaping the industry.BioMarin's recent decision to divest from its hemophilia A gene therapy, Roctavian, has garnered significant attention. Despite being the sole approved gene therapy for hemophilia A, Roctavian has struggled with sales since its ...

en-us

5:25

Biotech Breakthroughs: Transformative Acquisitions...

Pharma and BioTech Daily ·

2025/10/28

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into several significant shifts in the industry, marked by scientific advancements, regulatory changes, and strategic corporate maneuvers.Starting with a major acquisition, Novartis has strategically purchased Avidity Biosciences, a San Diego-based biotech company specializing in muscular dystrophy treatments, for a striking $12 billion. This...

en-us

5:58

Novartis' $12B RNA Therapeutics Breakthrough

Pharma and BioTech Daily ·

2025/10/27

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant shifts and strategies shaping our industry.Novartis’s acquisition of Avidity Biosciences for a staggering $12 billion marks a pivotal moment in the pharmaceutical landscape this year. With this acquisition, Novartis underscores its commitment to bolstering its neuromuscular disease pipeline. Avidity Biosciences h...

en-us

31:05

Week in Review - October 25, 2025

Pharma and BioTech Daily ·

2025/10/25

This week in review covers 5 episodes from October 20 to October 24, featuring major developments in pharmaceutical and biotech industries including strategic acquisitions, regulatory updates, and clinical trial results. Episodes included: 1. Pharma Innovations: AI's Impact and Strategic Shifts 2. Strategic Acquisitions and AI Revolutionize Pharma Landscape 3. Industry Shifts: Novo Nordisk's Revamp & ADC Breakthroughs 4. Transformative Advances in Precision Oncology and ADCs 5. Transforma...

en-us

6:15

Pharma Innovations: AI's Impact and Strategic Shifts

Pharma and BioTech Daily ·

2025/10/24

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into a series of significant events that are shaping the future of drug development and patient care.Starting with Merck KGaA, their decision to close the Active Pharmaceutical Ingredient plant in Arklow, Ireland by 2028 marks a pivotal shift in their manufacturing strategy. This move follows a strategic review and is emblematic of broad...

en-us

434 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci